Redefining Innovation
Jeffrey S. Handen, Ph.D
Collaborations of the Future
Melinda S. Shockley, Ph.D.
Portfolio Management: Selecting Right "Set of Projects" to Meet Product Development Goals
Arun Kejariwal
Funding and Resourcing Clinical Development
Michael A. Martorelli, CFA
Emerging Role of Patients in Clinical Research
Michael S. Katz
Innovative Organizations: Viewpoint of Organizational Scholars and Practitioners
Lindsey Kotrba,Ph.D., Ia Ko, Ph.D., and Daniel R. Denison, Ph.D.
Moving Toward Personalized Medicine; How to Transform Product Development
Michele Pontinen, Jian Wang, Ph.D., and Christopher Bouton, Ph.D.
Biography
Jeffrey S. Handen, PhD, is vice president of professional services with Medidata Solutions, Inc. Dr. Handen has published in multiple peer-reviewed and business journals, presented at numerous industry conferences and scientific meetings as an invited speaker, and served as past editor-in-chief of the Industrialization of Drug Discovery compendium. Before joining Medidata Solutions he was with Merck Research Laboratories for 6 years as a director of portfolio and project management helping to plan, manage, and execute Merck’s clinical development portfolio. Prior to Merck, Dr. Handen held management consulting positions with Computer Science Corporation and IBM Business Consulting Services (formerly PricewaterhouseCoopers Consulting). With over 20 years of experience in pharmaceutical and biotechnology research and development, process reengineering, and systems and process implementation, Dr. Handen has also held research and management positions with the University of Pennsylvania and the National Institutes of Health. As vice president of professional services for Medidata Solutions, Dr. Handen is responsible for overseeing clinical development business process integration, solution architecting for optimizing clinical trials design execution and development, implementation of data-driven metrics, and developing and implementing operational metrics to improve clinical research processes. He holds a PhD in neurosciences from George Washington University as well as a BS from Duke University.
